BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26525783)

  • 1. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
    Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.
    Li J; Zhang J; Li Q; Hu Y; Ruan Y; Tao Z; Xia H; Qiao J; Meng L; Zeng W; Li C; He X; Zhao L; Siddiqui FA; Miao J; Yang Z; Fang Q; Cui L
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008255. PubMed ID: 32530913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
    Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
    Fernández D; Segura C; Arboleda M; Garavito G; Blair S; Pabón A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6354-9. PubMed ID: 25114141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon.
    Silva SR; Almeida ACG; da Silva GAV; Ramasawmy R; Lopes SCP; Siqueira AM; Costa GL; Sousa TN; Vieira JLF; Lacerda MVG; Monteiro WM; de Melo GC
    Malar J; 2018 Jul; 17(1):267. PubMed ID: 30012145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon.
    Melo GC; Monteiro WM; Siqueira AM; Silva SR; Magalhães BM; Alencar AC; Kuehn A; del Portillo HA; Fernandez-Becerra C; Lacerda MV
    PLoS One; 2014; 9(8):e105922. PubMed ID: 25157811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Plasmodium vivax Chloroquine Resistance Transporter Mutant Isoforms.
    Hassett MR; Riegel BE; Callaghan PS; Roepe PD
    Biochemistry; 2017 Oct; 56(41):5615-5622. PubMed ID: 28898049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria.
    Fernández-Becerra C; Pinazo MJ; González A; Alonso PL; del Portillo HA; Gascón J
    Malar J; 2009 Apr; 8():55. PubMed ID: 19341456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.
    Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K
    Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
    Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
    Ganguly S; Saha P; Guha SK; Das S; Bera DK; Biswas A; Kundu PK; Saha B; Ray K; Maji AK
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1246-51. PubMed ID: 23262997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross.
    Sá JM; Kaslow SR; Moraes Barros RR; Brazeau NF; Parobek CM; Tao D; Salzman RE; Gibson TJ; Velmurugan S; Krause MA; Melendez-Muniz V; Kite WA; Han PK; Eastman RT; Kim A; Kessler EG; Abebe Y; James ER; Chakravarty S; Orr-Gonzalez S; Lambert LE; Engels T; Thomas ML; Fasinu PS; Serre D; Gwadz RW; Walker L; DeConti DK; Mu J; Bailey JA; Sim BKL; Hoffman SL; Fay MP; Dinglasan RR; Juliano JJ; Wellems TE
    Nat Commun; 2019 Sep; 10(1):4300. PubMed ID: 31541097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries.
    Lu F; Lim CS; Nam DH; Kim K; Lin K; Kim TS; Lee HW; Chen JH; Wang Y; Sattabongkot J; Han ET
    Acta Trop; 2011 Feb; 117(2):69-75. PubMed ID: 20933490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum.
    Sá JM; Yamamoto MM; Fernandez-Becerra C; de Azevedo MF; Papakrivos J; Naudé B; Wellems TE; Del Portillo HA
    Mol Biochem Parasitol; 2006 Dec; 150(2):219-28. PubMed ID: 16987557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
    Roesch C; Mairet-Khedim M; Kim S; Lek D; Popovici J; Witkowski B
    J Antimicrob Chemother; 2020 Jul; 75(7):1766-1771. PubMed ID: 32211790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon.
    Chehuan YF; Costa MR; Costa JS; Alecrim MG; Nogueira F; Silveira H; Brasil LW; Melo GC; Monteiro WM; Lacerda MV
    Malar J; 2013 Jul; 12():226. PubMed ID: 23819884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.